Analysts expect GRI Bio, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analysts expect GRI Bio, Inc. to report earnings per share of -0.89 for Q3 26, against a range of -0.95 to -0.83. The most recent reported quarter, Q2 26, came in at -0.91, a 22.2% beat against the -1.17 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -318.92 | -218.26 | -162.40 | -36.68 | -35.84 | -13.25 | -1.61 | -0.91 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | -314.09 | -139.40 | -92.18 | -32.10 | -27.44 | -26.73 | -1.51 | -1.11 | -0.83 | -0.73 | -0.92 | -0.88 | 36.98 | 55.16 | -14.83 | -21.61 | ||||||
| Low Estimate | -360.17 | -150.76 | -111.92 | -38.90 | -32.02 | -29.39 | -1.77 | -1.23 | -0.95 | -0.81 | -1.10 | -0.96 | 30.72 | 51.80 | -17.49 | -24.05 | ||||||
| Consensus Estimate | -337.13 | -145.08 | -102.05 | -35.50 | -29.73 | -28.06 | -1.64 | -1.17 | -0.89 | -0.77 | -1.01 | -0.92 | 33.85 | 53.48 | -16.16 | -22.83 |
Pull Wall Street consensus for GRI Bio, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=GRI&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "GRI", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=GRI&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();